Clinical Trials: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

Share this article:

Sponsor and Collaborators

National Cancer Institute (NCI)

Contact

NCI Referral Office

1-888-NCI-1937

ncicssc@mail.nih.gov

Principal Investigator

None indicated

ClinicalTrials.gov Identifier

NCT00942877

Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Sarcoma Clinical Trials

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Sarcoma Clinical Trials

Clinical Trial: Decitabine Followed by a Cancer Antigen Vaccine for Patients With ...

Clinical trial focusing on decitabine and cancer antigen vaccine. Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

Clinical Trial: A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin ...

Clinical trial focusing on TH-302 and Doxorubicin. A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Clinical Trial: Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue ...

Clinical trial focusing on sunitinib and radiation. Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma (SunRaSe)